For biologic-experienced patients hospitalized with acute severe ulcerative colitis, off-label, high-intensity doses of tofacitinib (Xeljanz) given with intravenous corticosteroids may have reduced ...
Individuals with IBD undergoing colectomy may benefit from surveillance for kidney function. Patients with inflammatory bowel disease (IBD) undergoing colectomy have higher rates of acute kidney ...
Advanced Therapies in Ulcerative Colitis: No Change in Colectomy Timing, High Incidental Cancer Rate
The increased use of advanced medical therapies has not extended the time to colectomy or reduced colorectal cancer (CRC) rates in patients with ulcerative colitis; however, an increased rate of ...
Please provide your email address to receive an email when new articles are posted on . Khatri and colleagues identified an ulcerative colitis disease gene signature by conducting a multi-cohort ...
The risk for colectomy declined over the past two decades among Finnish patients with newly diagnosed ulcerative colitis (UC), particularly between 2013 and 2020, when several advanced treatment ...
(A) Severe ulcerative colitis with ulceration and spontaneous bleeding (the Mayo Endoscopy Score =3); (B) Colitis-associated high-grade dysplasia in a flat rectal lesion (green arrows); (C) Normal ...
Observational cohort study of first-line bevacizumab combined with chemotherapy in metastatic colorectal cancer (HGCSG0802): Sub-group analysis by KRAS Exon2 status. This is an ASCO Meeting Abstract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results